Just-in-time CME now easier to utilize

Share this article:
Thanks to technical improvements, a form of online CME may finally realize its potential. Point-of-care (PoC) CME lets doctors earn credit for conducting structured online searches to answer clinical questions.

The format had been hampered by an inability for physicians to easily gain and claim credit online. The paperwork burden of processing half-credit units had posed the “biggest stumbling block” for providers thinking about offering it, said Laird Kelly, president of RSi Communications Group.

A free system Kelly has worked on for the last two years comes wrapped in a browser add-on slated for release next month. It lets physicians enter a query, scour a broad library of resources for answers and claim credit. Subscription-based services, such as UpToDate and Wiley’s InfoPOEMs/InfoRetriever, have added automated processing of credits online. The American College of Physicians told MM&M it is developing a tool to enable for-credit PoC searches with its PIER decision-support tool. Medscape expects to offer a version this year, as well.

Another hurdle had been a lack of credible sources, said Sondra Moylan, founder and president, AACME. Moylan, a joint sponsor of RSi’s search tool, helped assemble a medical advisory board to cull peer-reviewed, evidence-based resources. Other PoC providers employ physicians to write original content.

The AMA and AAFP award PoC credit for a three-step learning cycle: documenting the clinical question, sources consulted and the application to practice.

While industry surveys show a high level of physician interest in PoC, funding for non-subscription services remains an issue.

Share this article:

Next Article in News

Email Newsletters

More in News

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...

Pfizer Q2 sales slip, but still beat expectations

Pfizer Q2 sales slip, but still beat expectations

Patent losses and lost co-promotion agreements put a dent in sales.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?